Director/PDMR Shareholding

RNS Number : 6952J

IXICO plc

20 August 2019

 

20 August 2019

IXICO plc

("IXICO" or the "Company")

PDMR share option exercise

IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience, announces that on 20 August 2019, John Hall,  SVP Corporate Development, exercised 37,647 share options in the Company resulting in the allotment of new ordinary shares at a price of 30.5p.

John Hall is interested in 95,447 Ordinary Shares, representing 0.1 per cent of the enlarged issued share capital of the Company following the placing.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	John Hall
2	Reason for the notification
a)	Position/status	SVP Corporate Development
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	IXICO plc
b)	LEI	2138005M1F59O6HWSA97
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares in IXICO plc
	Identification code	GB00BCLY7L40
b)	Nature of the transaction	Exercise of share options
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			30.5p	37,647
d)	Aggregated information
	- Aggregated volume	37,647 shares
	- Price	30.5p
e)	Date of the transaction	20/08/19
f)	Place of the transaction	Outside of a trading venue

IXICO plc	[phone]
Giulio Cerroni, Chief Executive Officer Grant Nash, Chief Financial Officer
Cenkos Securities PLC (Nominated adviser and sole broker)	[phone]
Giles Balleny / Max Gould (Corporate Finance)
Michael F Johnson / Russell Kerr (Sales)
Optimum Strategic Communications	[phone]
Mary Clark / Anne Marieke Ezendam / Supriya Mathur
[e-mail]

 

END

 

 

DSHQBLFLKVFXBBZ